Learn more

GALLAGHER GRANT

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    205,774
About

GALLAGHER GRANT has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INST FOR VIRAL DISEASE CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION, INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE and INST MED BIOLOGY CAMS.

Patent filings in countries

World map showing GALLAGHER GRANTs patent filings in countries
# Country Total Patents
#1 United States 17

Patent filings per year

Chart showing GALLAGHER GRANTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gallagher Grant 17
#2 Yu Raymond 12
#3 Brazaitis Jonathan 9
#4 Gallagher Grant E 5
#5 Eskdale Joyce 4
#6 Megjugorac Nicholas 3
#7 Mancini Giacomo 3
#8 Kan Shih-Hsin 3
#9 Dai Jihong 2
#10 Siegel Rachael 2

Latest patents

Publication Filing date Title
US2016039878A1 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
US2014272994A1 Methods and reagents that specifically detect, distinguish and quantify IFN-λ2 mRNA from IFN-λ3 mRNA in humans
US2013172272A1 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
US2013029907A1 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
US2013035365A1 Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
US2012171704A1 Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
US2011268707A1 Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
US2009311694A1 Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases
US2012058081A1 Ex-vivo treatment of peripheral blood leukocytes with IFN-λ